BCMP1 inhibitors are a class of chemical compounds known for their ability to specifically bind to and inhibit the activity of the BCMP1 protein. BCMP1, or Brain and CNS Myelin Protein 1, is a protein involved in various intracellular signaling pathways, particularly in cellular processes related to the structural and functional dynamics of myelin within the central nervous system. Inhibitors of BCMP1 work by blocking or reducing the activity of this protein, potentially affecting cellular interactions and biochemical cascades related to myelin composition and maintenance. These inhibitors often interact with specific binding sites on the BCMP1 protein, leading to changes in its conformation and a subsequent decrease in its functional activity.
The inhibition of BCMP1 can be studied to better understand the protein's role in cellular homeostasis and its contribution to protein-protein interactions and signaling networks. Through various analytical methods, researchers can observe how BCMP1 inhibitors modulate specific pathways, contributing to a greater understanding of the molecular mechanisms that govern cellular function. Furthermore, BCMP1 inhibitors can serve as valuable tools in laboratory experiments designed to probe the function and structural features of the protein, helping to delineate the molecular relationships involved in BCMP1-associated signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX, a non-selective phosphodiesterase inhibitor, increases cAMP levels, potentially affecting BCMP1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C, which can modulate signaling pathways impacting BCMP1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium levels, potentially affecting pathways related to BCMP1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, which may indirectly influence BCMP1 activity through signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that could affect BCMP1 activity by modulating stress response pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, affecting pathways that could indirectly modulate BCMP1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, which may indirectly influence BCMP1 through the MAPK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may influence BCMP1 activity indirectly. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin affects multiple signaling pathways and could indirectly influence BCMP1 activity. | ||||||